Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Daniel, PT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Friedrich, K; Wieder, T; Von Haefen, C; Radetzki, S; Janicke, R; Schulze-Osthoff, K; Dorken, B; Daniel, PT
      Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance

      ONCOGENE
    2. Daniel, PT; Wieder, T; Sturm, I; Schulze-Osthoff, K
      The kiss of death: promises and failures of death receptors and ligands incancer therapy

      LEUKEMIA
    3. Wieder, T; Prokop, A; Bagci, B; Essmann, F; Bernicke, D; Schulze-Osthoff, K; Dorken, B; Schmalz, HG; Daniel, PT; Henze, G
      Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts

      LEUKEMIA
    4. Petrowsky, H; Sturm, I; Graubitz, O; Kooby, DA; Staib-Sebler, E; Gog, C; Kohne, CH; Hillebrand, T; Daniel, PT; Fong, Y; Lorenz, M
      Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    5. Sturm, I; Petrowsky, H; Volz, R; Lorenz, M; Radetzki, S; Hillebrand, T; Wolff, G; Hauptmann, S; Dorken, B; Daniel, PT
      Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: High BAX and p16(nk4a/CDKN2) identifies patients with good prognosis

      JOURNAL OF CLINICAL ONCOLOGY
    6. Raisova, M; Hossini, AM; Eberle, J; Riebeling, C; Wieder, T; Sturm, I; Daniel, PT; Orfanos, CE; Geilen, CC
      The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    7. Hermann, S; Sturm, I; Mrozek, A; Klosterhalfen, B; Hauptmann, S; Dorken, B; Daniel, PT
      Bax expression in benign and malignant thyroid tumours: Dysregulation of wild-type p53 is associated with a high bax and p21 expression in thyroid carcinoma

      INTERNATIONAL JOURNAL OF CANCER
    8. Wieder, T; Essmann, F; Prokop, A; Schmelz, K; Schulze-Osthoff, K; Beyaert, R; Dorken, B; Daniel, PT
      Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream ofcaspase-3

      BLOOD
    9. Prokop, A; Wieder, T; Sturm, I; Essmann, E; Seeger, K; Wuchter, C; Ludwig, WD; Henze, G; Dorken, B; Daniel, PT
      Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

      LEUKEMIA
    10. Daniel, PT
      Dissecting the pathways to death

      LEUKEMIA
    11. Essmann, F; Wieder, T; Otto, A; Muller, EC; Dorken, B; Daniel, PT
      GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous Rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis

      BIOCHEMICAL JOURNAL
    12. Sturm, I; Papadopoulos, S; Hillebrand, T; Benter, T; Luck, HJ; Wolff, G; Dorken, B; Daniel, PT
      Impaired BAX protein expression in breast cancer: Mutational analysis of the BAX and the p53 gene

      INTERNATIONAL JOURNAL OF CANCER
    13. Loffler, A; Kufer, P; Lutterbuse, R; Zettl, F; Daniel, PT; Schwenkenbecher, JM; Riethmuller, G; Dorken, B; Bargou, RC
      A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes

      BLOOD
    14. Daniel, PT; Sturm, I; Wolff, G; Petrowsky, H; Kohne, CH; Hillebrand, T; Dorker, B; Lorenz, M
      Analysis of the p53/BAX pathway: Low BAX expression is a negative prognostic factor in patients with resected liver metastases of colorectal adenocarcinoma

      LANGENBECKS ARCHIVES OF SURGERY
    15. Sturm, I; Kohne, CH; Wolff, G; Petrowsky, H; Hillebrand, T; Hauptmann, S; Lorenz, M; Dorken, B; Daniel, PT
      Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases

      JOURNAL OF CLINICAL ONCOLOGY
    16. Daniel, PT; Scholz, C; Essmann, F; Westermann, J; Pezzutto, A; Dorken, B
      CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism

      EXPERIMENTAL HEMATOLOGY
    17. Daniel, PT; Pun, KT; Ritschel, S; Sturm, I; Holler, J; Dorken, B; Brown, R
      Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice

      BLOOD
    18. Daniel, PT; Sturm, I; Ritschel, S; Friedrich, K; Dorken, B; Bendzko, P; Hillebrand, T
      Detection of genomic DNA fragmentation during apoptosis (DNA ladder) and the simultaneous isolation of RNA from low cell numbers

      ANALYTICAL BIOCHEMISTRY
    19. Daniel, PT; Pezzutto, A; Dorken, B
      Humoral immunotherapy and the use of monoclonal antibodies

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    20. KOHNE CH; THUSSPATIENCE P; FRIEDRICH M; DANIEL PT; KRETZSCHMAR A; BENTER T; BAUER B; DIETZ R; DORKEN B
      RALTITREXED (TOMUDEX) - AN ALTERNATIVE DRUG FOR PATIENTS WITH COLORECTAL-CANCER AND 5-FLUOROURACIL ASSOCIATED CARDIOTOXICITY

      British Journal of Cancer
    21. Daniel, PT; Kroidl, A; Kopp, J; Sturm, I; Moldenhauer, G; Dorken, B; Pezzutto, A
      Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: Costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic Tcells

      BLOOD
    22. DANIEL PT; KROIDL A; BARGOU R; CAYEUX S; BLANKENSTEIN T; PEZZUTTO A; DORKEN B
      COSTIMULATORY SIGNALS THROUGH INTERACTION OF B7.1 AND CD28 PREVENT VETO DEATH OF CYTOTOXIC T-CELLS DURING TUMOR TARGET-CELL LYSIS

      European journal of cancer
    23. DANIEL PT; SCHOLZ C; WESTERMANN J; DAEMEN K; DORKEN B; PEZZUTTO A
      ACTIVATION-INDUCED CELL-DEATH OF T-CELLS IS PREVENTED BY COCULTURE WITH DENDRITIC CELLS

      European journal of cancer
    24. DANIEL PT; KROIDL A; PEZZUTTO A; MOLDENHAUER G; DORKEN B
      COSTIMULATION WITH AGONISTIC ANTI-CD28 ANTIBODIES PREVENTS T-CELL APOPTOSIS AND IS REQUIRED FOR EFFICIENT IMMUNOTHERAPY WITH CD3X19 BISPECIFIC ANTIBODIES IN B-CELL LYMPHOMA

      European journal of cancer
    25. DANIEL PT; KROIDL A; CAYEUX S; BLANKENSTEIN T; PEZZUTTO A; DORKEN B
      B7.1 GENE-TRANSFER IN CANCER-CELLS PROTECTS CYTOTOXIC T-CELLS FROM DELETION BY APOPTOSIS

      Cancer gene therapy
    26. DANIEL PT; SCHOLZ C; WESTERMANN J; DAEMEN K; DORKEN B; PEZZUTTO A
      DENDRITIC CELLS PROTECT T-CELLS FROM ACTIVATION-INDUCED APOPTOSIS VIAA CD58 AND B7.1 2 DEPENDENT PATHWAY/

      Cancer gene therapy
    27. DANIEL PT; KROIDL A; CAYEUX S; BARGOU R; BLANKENSTEIN T; DORKEN B
      COSTIMULATORY SIGNALS THROUGH B7.1 CD28 PREVENT T-CELL APOPTOSIS DURING TARGET-CELL LYSIS/

      The Journal of immunology
    28. DANIEL PT; OETTINGER U; MAPARA MY; BOMMERT K; BARGOU R; DORKEN B
      ACTIVATION AND ACTIVATION-INDUCED DEATH OF HUMAN TONSILLAR B-CELLS AND BURKITT-LYMPHOMA CELLS - LACK OF CD95 (FAS APO-1) LIGAND EXPRESSION AND FUNCTION/

      European Journal of Immunology
    29. DANIEL PT; KROIDL A; CAYEUX S; BLANKENSTEIN T; PEZZUTTO A; DORKEN B
      RETROVIRAL B7.1 GENE-TRANSFER IN BREAST-CANCER CELLS PROTECTS ALLOREACTIVE CYTOTOXIC T-CELLS FROM DELETION BY APOPTOSIS

      Blood
    30. MAPARA MY; BOMMERT K; BARGOU R; DANIEL PT; STILGENBAUER S; BENNER A; LICHTER P; DORKEN B; DOHNER H
      PROGNOSTIC-SIGNIFICANCE OF BCL-2 EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Blood
    31. DANIEL PT; RITSCHEL S; BROWN R; PEZZUTTO A; KOHNE CH; DORKEN B
      BIK NBK-1, AN APOPTOSIS PROMOTING MEMBER OF THE BCL-2 FAMILY, INCREASES DRUG-SENSITIVITY MATURE T-LEUKEMIA-CELLS/

      Blood
    32. BARGOU RC; WAGENER C; BOMMERT K; ARNOLD W; DANIEL PT; MAPARA MY; GRINSTEIN E; ROYER HD; DORKEN B
      BLOCKING OF TRANSCRIPTION FACTOR E2F DP BY DOMINANT-NEGATIVE MUTANTS IN A NORMAL BREAST EPITHELIAL-CELL LINE EFFICIENTLY INHIBITS APOPTOSISAND INDUCES TUMOR-GROWTH IN SCID MICE/

      The Journal of experimental medicine
    33. WAGENER C; BARGOU RC; DANIEL PT; BOMMERT K; MAPARA MY; ROYER HD; DORKEN B
      INDUCTION OF THE DEATH-PROMOTING GENE BAX-ALPHA SENSITIZES CULTURED BREAST-CANCER CELLS TO DRUG-INDUCED APOPTOSIS

      International journal of cancer
    34. DANIEL PT; KROIDL A; LANGNER K; KOHNE CH; DORKEN B
      INDUCTION OF THE CD95 (FAS APO-1) LIGAND - AN ALTERNATIVE MECHANISM IN CYTOSTATIC DRUG-INDUCED APOPTOSIS WHICH IS ACTIVE IN T-LYMPHOID BUT NOT B-LYMPHOID AND BREAST-CANCER CELLS/

      Blood
    35. DANIEL PT; HEMPEL C; BOMMERT K; BARGOU RC; MAPARA MY; DORKEN B
      TRIGGERING OF THE B-CELL ANTIGEN RECEPTOR PREVENTS CD95 (APO-1 FAS) MEDIATED APOPTOSIS OF CD40 LIGAND-ACTIVATED B-CELLS/

      Blood
    36. CHLICHLIA K; MOLDENHAUER G; DANIEL PT; BUSSLINGER M; GAZZOLO L; SCHIRRMACHER V; KHAZAIE K
      IMMEDIATE EFFECTS OF REVERSIBLE HTLV-I TAX FUNCTION - T-CELL ACTIVATION AND APOPTOSIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    37. CHLICHLIA K; MOLDENHAUER G; DANIEL PT; BUSSLINGER M; GAZZOLO L; SCHIRRMACHER V; KHAZAIE K
      IMMEDIATE EFFECTS OF REVERSIBLE HTLV-1 TAX FUNCTION - T-CELL ACTIVATION AND APOPTOSIS

      Oncogene
    38. BARGOU RC; BOMMERT K; MAPARA MY; DANIEL PT; DORKEN B
      CONSTITUTIVE NUCLEAR-BINDING ACTIVITY OF NF-KAPPA-B AND OCT-2 ARE A COMMON AND SPECIFIC FEATURE OF CULTURED AND PRIMARY HODGKIN CELLS

      Experimental hematology
    39. DANIEL PT; MAPARA MY; BOMMERT K; BARGOU RC; KRAMMER P; DORKEN B
      CD95 (APO-1 FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS/

      Experimental hematology
    40. BARGOU RC; BOMMERT K; MAPARA MY; DANIEL PT; DORKEN B
      SEQUENTIAL INDUCTION OF THE TRANSCRIPTION FACTOR NAK-1 AND BAX-ALPHA PRECEDES APOPTOSIS IN HUMAN BURKITT-LYMPHOMA

      Experimental hematology
    41. DANIEL PT; PANKOW RW; MAPARA MY; BOMMERT K; BARGOU RC; DORKEN B
      NAK-1, THE HUMAN NUR77 HOMOLOG, AND THE CD95 ANTIGEN (APO-1 FAS) ARE SEQUENTIALLY INVOLVED IN NORMAL AND MALIGNANT T-CELL APOPTOSIS/

      Experimental hematology
    42. LAGRESLE C; BELLA C; DANIEL PT; KRAMMER PH; DEFRANCE T
      REGULATION OF GERMINAL CENTER B-CELL DIFFERENTIATION - ROLE OF THE HUMAN APO-1 FAS (CD95) MOLECULE/

      The Journal of immunology
    43. BARGOU RC; DANIEL PT; MAPARA MY; BOMMERT K; WAGENER C; KALLINICH B; ROYER HD; DORKEN B
      EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS

      International journal of cancer
    44. BLASE L; DANIEL PT; KORETZ K; SCHWARTZALBIEZ R; MOLLER P
      THE CAPACITY OF HUMAN-MALIGNANT B-LYMPHOCYTES TO DISSEMINATE IN SCID MICE IS CORRELATED WITH FUNCTIONAL EXPRESSION OF THE FIBRONECTIN RECEPTOR ALPHA(5)BETA(1) (CD49E CD29)/

      International journal of cancer
    45. MAPARA MY; WEINMANN P; BOMMERT K; DANIEL PT; BARGOU R; DORKEN B
      INVOLVEMENT OF NAK-1, THE HUMAN NUR77 HOMOLOG, IN SURFACE IGM-MEDIATED APOPTOSIS IN BURKITT-LYMPHOMA CELL-LINE BL41

      European Journal of Immunology
    46. BARGOU RC; BOMMERT K; WEINMANN P; DANIEL PT; WAGENER C; MAPARA MY; DORKEN B
      INDUCTION OF BAX-ALPHA PRECEDES APOPTOSIS IN A HUMAN B-LYMPHOMA CELL-LINE - POTENTIAL ROLE OF THE BCL-2 GENE FAMILY IN SURFACE IGM-MEDIATEDAPOPTOSIS

      European Journal of Immunology
    47. BARGOU RC; BOMMERT K; DANIEL PT; MAPARA MY; SCHEIDEREIT C; DORKEN B
      HIGH-LEVEL NUCLEAR NF-KAPPA-B AND OCT-2 ARE A COMMON FEATURE OF TUMOR-CELLS FROM PATIENTS WITH HODGKINS-DISEASE

      Blood
    48. BARGOU RC; BOMMERT K; DANIEL PT; MAPARA MY; ROYER HD; DORKEN B
      INDUCTION OF BAX-ALPHA PRECEDES APOPTOSIS IN HUMAN BURKITT-LYMPHOMA CELLS - POTENTIAL ROLE OF THE BCL-2 GENE FAMILY IN SURFACE IGM MEDIATEDAPOPTOSIS

      Blood
    49. DANIEL PT; OETTINGER U; MAPARA MY; BOMMERT K; BARGOU RC; DORKEN B
      CD95 (APO-1 FAS) AND THE FAS LIGAND IN ACTIVATION-INDUCED CELL-DEATH (AICD) OF B-CELLS/

      Blood
    50. LUCKINGFAMIRA KM; DANIEL PT; MOLLER P; KRAMMER PH; DEBATIN KM
      APO-1 (CD95) MEDIATED APOPTOSIS IN HUMAN T-ALL ENGRAFTED IN SCID MICE

      Leukemia
    51. BARGOU RC; MAPARA MY; BOMMERT K; DANIEL PT; ZUGCK C; DORKEN B
      REGULATION OF PROLIFERATION IN THE NEW HODGKIN CELL-LINE HD-MYZ BY ANTISENSEOLIGONUCLEOTIDES AGAINST IL-6 AND IL-8

      Journal of cellular biochemistry
    52. DHEIN J; BEHRMANN I; DANIEL PT; DEBATIN KM; KLAS C; MOLLER P; OEHM A; TRAUTH BC; WALCZAK H; KRAMMER PH
      APO-1-MEDIATED APOPTOSIS IN NORMAL AND MALIGNANT LYMPHOCYTES

      Biochemical Society transactions
    53. KRAMMER PH; DHEIN J; WALCZAK H; BEHRMANN I; MARIANI S; MATIBA B; FATH M; DANIEL PT; KNIPPING E; WESTENDORP MO; STRICKER K; BAUMLER C; HELLBARDT S; GERMER M; PETER ME; DEBATIN KM
      THE ROLE OF APO-1-MEDIATED APOPTOSIS IN THE IMMUNE-SYSTEM

      Immunological reviews
    54. DANIEL PT; KRAMMER PH
      ACTIVATION INDUCES SENSITIVITY TOWARD APO-1 (CD95)-MEDIATED APOPTOSISIN HUMAN B-CELLS

      The Journal of immunology
    55. CONEY LR; DANIEL PT; SANBORN D; DHEIN J; DEBATIN KM; KRAMMER PH; ZURAWSKI VR
      APOPTOTIC CELL-DEATH INDUCED BY A MOUSE-HUMAN ANTI-APO-1 CHIMERIC ANTIBODY LEADS TO TUMOR-REGRESSION

      International journal of cancer
    56. BARGOU RC; MAPARA MY; ZUGCK C; DANIEL PT; PAWLITA M; DOHNER H; DORKEN B
      CHARACTERIZATION OF A NOVEL HODGKIN CELL-LINE, HD-MYZ, WITH MYELOMONOCYTIC FEATURES MIMICKING HODGKINS-DISEASE IN SEVERE COMBINED IMMUNODEFICIENT MICE

      The Journal of experimental medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 03:34:39